Supernus, Inc. has made a notable adjustment to its 0.625% Convertible Senior Notes due 2031, increasing the conversion rate as a result of a Special Dividend declared by its board.

The conversion rate per $1,000 principal amount of Notes has been raised from 24.0033 shares to 30.9355 shares of the company's common stock. This change reflects a new conversion price of approximately $32.33 per share. The company noted that the conversion rate is subject to customary adjustments upon the occurrence of certain events as described in the Indenture.

No bondholders converted their bonds for common stock at this time. This decision may affect the company's capital structure and investor engagement moving forward.

Background

Supernus, Inc., incorporated in Delaware, is classified under the SIC code 2834, which pertains to Pharmaceutical Preparations. The company trades on the Nasdaq under the ticker symbol SUPN. Recent filings include a Form 8-K on November 3, 2026, detailing the conversion rate adjustment.

What the Filing Says

Pursuant to the terms of the Indenture, the conversion rate per $1,000 principal amount of Notes has been increased from 24.0033 shares of the Company’s common stock to 30.9355 shares of the Company’s common stock.

Impact

This adjustment may influence bondholders and investors in the pharmaceutical industry, as it alters the terms of the company's debt and equity relationship. It could also impact other companies in the pharmaceutical preparations sector as they evaluate similar financial instruments in light of market conditions.

What's Next

The filing does not say what happens next.